Shufro Rose & Co. LLC trimmed its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 61,032 shares of the medical research company’s stock after selling 275 shares during the quarter. Thermo Fisher Scientific comprises 1.1% of Shufro Rose & Co. LLC’s portfolio, making the stock its 27th biggest holding. Shufro Rose & Co. LLC’s holdings in Thermo Fisher Scientific were worth $10,648,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in TMO. Proficio Capital Partners LLC raised its holdings in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after buying an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC bought a new position in shares of Thermo Fisher Scientific in the second quarter valued at about $108,000. Cribstone Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after buying an additional 50 shares during the last quarter. Sharkey Howes & Javer raised its holdings in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after buying an additional 7 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. bought a new position in shares of Thermo Fisher Scientific in the second quarter valued at about $113,000. 83.36% of the stock is owned by institutional investors and hedge funds.

A number of research analysts recently issued reports on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target for the company in a report on Thursday. Deutsche Bank AG set a $200.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Saturday, June 10th. BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Barclays PLC reaffirmed an “overweight” rating and issued a $200.00 price target (up from $190.00) on shares of Thermo Fisher Scientific in a report on Monday, July 17th. Finally, Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. One equities research analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $194.33.

In other news, Director Jim P. Manzi sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $175.20, for a total transaction of $175,200.00. Following the completion of the transaction, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Seth H. Hoogasian sold 4,140 shares of the firm’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $177.80, for a total value of $736,092.00. Following the transaction, the vice president now owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Insiders have sold 52,738 shares of company stock valued at $9,302,112 over the last 90 days. 0.49% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This news story was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.dailypolitical.com/2017/09/23/thermo-fisher-scientific-inc-tmo-shares-sold-by-shufro-rose-co-llc.html.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 188.30 on Friday. The stock’s 50 day moving average price is $181.07 and its 200 day moving average price is $171.15. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30. The firm has a market capitalization of $73.46 billion, a price-to-earnings ratio of 32.80 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same period last year, the company earned $2.03 earnings per share. The business’s quarterly revenue was up 10.2% on a year-over-year basis. On average, equities analysts anticipate that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.